Advanced search
Publication Cover
Gynecological Endocrinology Volume 38, 2022 - Issue 10
Submit an article Journal homepage
135
Views
0
CrossRef citations to date
0
Altmetric
Menopause

A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women

Mukun Yanga Beijing Shijitan Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Shouqing Linb Peking Union Medical College Hospital, Beijing, ChinaView further author information
,
Shurong Zhengc Peking University First Hospital, Beijing, ChinaView further author information
,
Aijun Sunb Peking Union Medical College Hospital, Beijing, ChinaView further author information
,
Meilu Biand China-Japan Friendship Hospital, Beijing, ChinaView further author information
,
Shilan Lie Peking University Third Hospital, Beijing, ChinaView further author information
,
Jianli Liuf Chinese PLA General Hospital, Beijing, ChinaView further author information
,
Lina Hug The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information
,
Ning Huih Changhai Hospital of Shanghai, Shanghai, ChinaView further author information
,
Jing Zhongi Chengdu Maternity and Child Care Hospital, Chengdu, ChinaView further author information
,
Hongchun Houj Jinan Maternity and Child Care Hospital, Jinan, ChinaView further author information
,
Tianfu Yuek Tianjin Medical University General Hospital, Tianjin, ChinaView further author information
,
Xiaoli Gaol College of Pharmacy, Xinjiang Medical University, Xinjiang, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Wenpei Baia Beijing Shijitan Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 861-867 | Received 13 Jun 2022, Accepted 24 Aug 2022, Published online: 06 Sep 2022

References

  • Seyyedi F, Kopaei MR, Miraj S. Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study. Electron Physician. 2016;8(11):3184–3192.
  • Poomalar GK, Arounassalame B. The quality of life during and after menopause among rural women. J Clin Diagn Res. 2013;7(1):135–139.
  • Shen J, Song N, Williams CJ, et al. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. Sci Rep. 2016;6(1):24380.
  • Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019;36(10):897–908.
  • Shim S, Park KM, Chung YJ, et al. Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements. J Menopausal Med. 2021;27(1):1–7.
  • Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
  • Scavello I, Maseroli E, Di Stasi V, et al. Sexual health in menopause. Medicina (Kaunas). 2019;55(9):559.
  • Briggs P. Genitourinary syndrome of menopause. Post Reprod Health. 2020;26(2):111–114.
  • Hocke C, Diaz M, Bernard V, et al. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]. Gynecol Obstet Fertil Senol. 2021;49(5):394–413.
  • Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause (New York, NY). 2013;20(9):888–902. quiz 3-4.
  • Simon JA, Reape KZ, Wininger S, et al. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Fertil Steril. 2008;90(4):1132–1138.
  • Baber RJ, Panay N, Fenton A, Group IMSW. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
  • Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women’s Sexual Health. Menopause. 2018;25(6):596–608.
  • The NGSMPSEP. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause (New York, NY). 2020;27(9):976–992.
  • Suwanvesh N, Manonai J, Sophonsritsuk A, et al. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause (New York, NY). 2017;24(2):210–215.
  • Palacios S, Losa F, Dexeus D, et al. Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women. BMC Womens Health. 2017;17(1):21.
  • Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–1849.
  • Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586.
  • Nappi RE, Martini E, Cucinella L, et al. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol (Lausanne). 2019;10:561.
  • Bachmann G, Bouchard C, Hoppe D, et al. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally. Menopause (New York, NY). 2009;16(4):719–727.
  • Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500.
  • Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221–1231.
  • Hawkes N. HRT increases risk of blood clots and stroke, finds new analysis. BMJ. 2015;350:h1336.
  • Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351–358.
  • Perez-Lopez FR, Vieira-Baptista P, Phillips N, et al. Clinical manifestations and evaluation of. Postmenopausal vulvovaginal atrophy. Gynecol Endocrinol. 2021;37(8):740–745.
  • Samsioe G. Urogenital aging–a hidden problem. Am J Obstet Gynecol. 1998;178(5):S245–S9.
  • Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61(10):3090–3096.
  • Carcio H. Urogenital atrophy. A new approach to vaginitis diagnosis. Adv Nurse Pract. 2002;10(10):40–48, 51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.